valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
SWX:NOVN
Novartis
|
93.17 | 8.38% | 21.78% | 190,104.66 | 3.54% | 4.67% |
|
NYSE:PFE
Pfizer
|
28.66 | 8.34% | 38.56% | 162,404.55 | 5.86% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
89.76 | 18.57% | 37.41% | 112,210.49 | 4.19% | 8.19% |
|
TSE:4568
Daiichi Sankyo Company
|
5578.00 | 0% | 0% | 10,692,719.71 | 1.08% | 0% |
|
NasdaqGS:MRNA
Moderna
|
142.55 | -,109.99% | -,106.89% | 54,630.82 | 0% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4173.00 | 0% | 0% | 6,547,160.96 | 4.7% | 0% |
|
NasdaqGS:BIIB
Biogen
|
224.94 | -13.1% | 2.32% | 32,750.57 | 0% | -10.89% |
|
XTRA:BAYN
Bayer
|
28.24 | 69.55% | 86.07% | 27,743.66 | 0.39% | 1.47% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
148.43 | 0% | 0% | 18,775.17 | 0% | 0% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
75.07 | 154.97% | 238.58% | 14,615.05 | 0% | 32.46% |
|
NasdaqGS:SRPT
Sarepta Therapeutics
|
129.86 | 0% | 0% | 12,505.49 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
105.56 | 0% | 0% | 6,783.92 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
37.57 | -,156.68% | -,149.23% | 5,756.54 | 0% | 0% |
|
NasdaqGS:DYN
Dyne Therapeutics
|
31.88 | 0% | 0% | 2,267.58 | 0% | 0% |
|
TSE:4516
Nippon Shinyaku
|
3073.00 | 0% | 0% | 261,328.78 | 4.04% | 0% |
|
NasdaqGM:WVE
Wave Life Sciences
|
6.18 | 0% | 0% | 688.23 | 0% | 0% |
|
NasdaqGS:STOK
Stoke Therapeutics
|
14.62 | 0% | 0% | 604.59 | 0% | 0% |
|
NasdaqGS:ABUS
Arbutus Biopharma
|
3.36 | 0% | 0% | 535.96 | 0% | 0% |
|
NasdaqGM:FULC
Fulcrum Therapeutics
|
7.85 | 0% | 0% | 456.83 | 0% | 0% |
|
ASX:PYC
PYC Therapeutics
|
0.11 | 0% | 0% | 466.61 | 0% | 0% |
